University Of Medicine And Dentistry Of New Jersey
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1970-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.umdnj.edu/
Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2017-04-25
- Target Recruit Count
- 13
- Registration Number
- NCT00143819
Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer
- Conditions
- Interventions
- First Posted Date
- 2005-08-30
- Last Posted Date
- 2013-11-20
- Target Recruit Count
- 33
- Registration Number
- NCT00138151
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸UMDNJ University Hospital, Newark, New Jersey, United States
🇺🇸Carol G. Simon Cancer Center at Morristown Memorial Hospital, Morristown, New Jersey, United States
Etanercept With Tacrolimus for Psoriasis
- Conditions
- First Posted Date
- 2005-08-24
- Last Posted Date
- 2008-08-07
- Target Recruit Count
- 20
- Registration Number
- NCT00134394
- Locations
- 🇺🇸
UMDNJ Psoriasis Center of Excellence, New Brunswick, New Jersey, United States
Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo
- Conditions
- First Posted Date
- 2005-08-24
- Last Posted Date
- 2008-08-07
- Target Recruit Count
- 40
- Registration Number
- NCT00134368
- Locations
- 🇺🇸
UMDNJ Psoriasis Center of Excellence, New Brunswick, New Jersey, United States
Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder
- First Posted Date
- 2005-07-21
- Last Posted Date
- 2008-06-10
- Target Recruit Count
- 15
- Registration Number
- NCT00122070
- Locations
- 🇺🇸
University of Medicine and Dentistry of New Jersey - School of Osteopathic Medicine - Department of Psychiatry, Cherry Hill, New Jersey, United States
Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin
- Conditions
- Locations
- 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
🇺🇸Cancer Institute of New Jersey at Hamilton, Hamilton, New Jersey, United States
🇺🇸Hematology and Oncology Group, Somerset, New Jersey, United States
Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2023-08-15
- Target Recruit Count
- 49
- Registration Number
- NCT00118131
- Locations
- 🇺🇸
UMDNJ - University Hospital, Newark, New Jersey, United States
🇺🇸Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
🇺🇸JFK Medical Center in Edison, Edison, New Jersey, United States
Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2013-11-20
- Target Recruit Count
- 5
- Registration Number
- NCT00118053
- Locations
- 🇺🇸
Saint Peter's University Hospital, New Brunswick, New Jersey, United States
🇺🇸Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
🇺🇸UMDNJ University Hospital, Newark, New Jersey, United States
Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
- Conditions
- Locations
- 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
Sulindac and Plant Compounds in Preventing Colon Cancer
- Conditions
- Locations
- 🇺🇸
Rockefeller University Hospital, New York, New York, United States